GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and non-ligated mice

European Journal of Pharmacology

Volumn 407, Issue 1-2, 2000, Pages 65-72

  Zarrindast, Mohammad Reza ^a   Valizadeh, Sadegh ^b   Sahebgharani, Mousa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Baclofen; Hot plate test; Imipramine; Ligation; Mouse

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; IMIPRAMINE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; LIGATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMAL; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BACLOFEN; GABA AGONISTS; GABA ANTAGONISTS; IMIPRAMINE; LIGATION; MALE; MICE; MORPHINE; ORGANOPHOSPHORUS COMPOUNDS; PAIN MEASUREMENT; RECEPTORS, GABA-B; SCIATIC NERVE;

EID: 0034721952     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00648-8     Document Type: Article

References (54)

1. Antagonism of baclofen-induced antinociception by intrathecal administration of phaclofen or 2-hydroxy-saclofen, but not δ-aminovaleric acid in the rat
2. Antinociceptive effects of acute and chronic injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats
3. 3 receptor-mediated antinociception: possible release of GABA
4. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
5. Reduced plasma and CSF GABA in affective illness: effect of lithium carbonate
6. Biochemistry, electrophysiology and pharmacology of a new GABA(B) antagonist: CPG35348
7. GABA(B) receptor pharmacology
8. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by action at a novel GABA receptors
9. Characteristics of GABA(B) receptor binding sites on rat whole brain synaptic membrane
10. Role of glutamate receptors and nitric oxide in the rostal ventromedial medulla in visceral hyperalgesia
11. Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism
12. Pain mechanisms
13. Synthetic analgesics: II. Dithienylbutyl and dithienylbutylamines
14. Pain relief by antidepressants: possible modes of action
15. Psychogenic pain: presentation and treatment
16. Can opiates relieve neuropathic pain?
17. Multiple mechanisms of neuropathic pain: a clinical perspective
18. Time-course of nociceptive disorders induced by chronic loose ligatures of the rat sciatic nerve and changes of the acetylcholinesterase transport along the ligated nerve
19. Baclofen in the treatment of trigeminal neuralgia: double blind study and long-term follow up
20. CSF GABA levels in normal subjects and patients with depression, schizophrenia, mania and anorexia
21. Antidepressants: receptors pharmacokinetics, and clinical effects
22. GABA(B)-receptor mediated inhibition of potassium evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex
23. Morphine responsiveness of chronic pain - double blind randomized crossover study with patient-controlled analgesia
24. Selective modulation of morphine antinociception, but not development of tolerance by receptor
25. Upregulation of γ-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock
26. The pharmacology of adenylyl cyclase modulation by GABA(B) receptors in rat brain slices
27. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain
28. The use of antidepressants in the treatment of chronic pain: a review of current evidence
29. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
30. Association of pain relief with drug side effects in postherptic neuralgia: a single-dose study of clonidine, codeine, ibuprofen and placebo
31. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy
32. CGP35348: a centrally active blocker of GABA(B) receptors
33. Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression
34. Benzodiazepines as antidepressants: does GABA play a role in depression
35. Potentiation of opioid analgesia by the antidepressant nefazodone
36. Results of international clinical trials with Lioresal
37. Baclofen: effects on amino acid release and metabolism in slices of guinea-pig cerebral cortex
38. γ-Aminobutyric acid can both inhibit and facilitate dopamine release in the caudate nucleus of the rabbit
39. Both intravenous lidocaine and morphine reduce the pain of post-herpetic neuralgia
40. Antinociception: interaction between adenosine and GABA systems
41. Baclofen and antidepressant-induced antinociception in formalin test: possible GABA(B) mechanism involvement
42. GABAergic mechanisms of analgesia: an update
43. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies
44. A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury in rats
45. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge
46. Clinical trials and therapeutics: the selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy
47. The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain
48. Neuropathic pain can be relieved by drugs that are use-dependant sodium channel blockers: lidocaine, carbamozepine and mexiletine
49. Central inhibitory disfunction: mechanism and clinical implication
50. The pathophysiology of chronic pain-increased sensitivity to low threshold AB-fiber inputs
51. Drug therapy: spasticity
52. GABA(A) antagonists and baclofen analgesia
53. Influences of dopamine agonists and antagonists on baclofen antinociception in mice
54. Stress-induced antinociception and GABAergic mechanism